Merck & Co is one of the investors set to exit antibody drug developer Visterra after Otsuka Pharmaceutical agreed to buy the company for $430m.
The SIG-backed digital media company is reportedly considering an initial public offering in its home country.
The JD.com, Xiaomi, InTime and SIG-backed personal finance product provider is set to price its shares at the bottom of the IPO's range.
Unternehmertum Venture Capital Partners has agreed to sell its shares in AMW as part of an acquisition led by Hybio Pharmaceutical and Yunfeng Capital.
CBRE and corporate venturing units GV and M12 exited as Siemens bought Building Robotics, the developer of building environmental control app Comfy.
The online lending marketplace, which counts Alibaba, Tom Group, Nan Fung, ING and Ule as investors, was previously reported to be targeting $500m.
Intel Capital will sell shares in an initial public offering in which e-commerce marketplace IndiaMart is expected to raise up to $88m.
Liquidia Technologies, a spinout from UNC Chapel Hill, has filed to raise up to $57.5m in its initial public offering.
PPD and Siemens-backed biopharmaeutical developer Liquidia Technologies has filed to raise up to $57.5m in its initial public offering.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
